Published in Transplantation on May 01, 1987
Bone marrow transplantation. Part I--Allogeneic. West J Med (1989) 0.88
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood (1998) 6.26
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med (2001) 5.59
Ribozymes as potential anti-HIV-1 therapeutic agents. Science (1990) 4.49
Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med (1989) 4.20
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet (1995) 4.07
Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med (1996) 4.07
Prostaglandins modulate macrophage Ia expression. Nature (1982) 3.83
Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol (1982) 3.61
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother (1979) 3.61
AIDS--an immunologic reevaluation. N Engl J Med (1984) 3.53
The acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.49
A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group. N Engl J Med (1991) 3.05
Immunoglobulin changes in disease: quantitation on the basis of heavy polypeptide chains, IgG (gammaG), IgA (gammaA), and IgM (gammaM), and of light polypeptide chains, type K (I) and type L (II). J Clin Invest (1965) 3.00
Tretinoin toxicity in children with acute promyelocytic leukaemia. Lancet (1993) 2.85
Limited periods of gene expression in immunoglobulin-synthesizing cells. Science (1969) 2.77
Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells. J Infect Dis (1977) 2.65
Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am J Med (1984) 2.60
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med (1997) 2.55
Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol (1994) 2.50
Relation between sexual practices and T-cell subsets in homosexually active men. Lancet (1983) 2.46
Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity. Psychosom Med (1996) 2.40
Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry (1993) 2.38
THE METABOLISM OF NORMAL PLASMA PROTEINS AND GAMMA-MYELOMA PROTEIN IN MICE BEARING PLASMA-CELL TUMORS. J Clin Invest (1961) 2.32
Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol (1989) 2.27
Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol (1999) 2.15
Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol (1987) 2.11
CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr (1989) 2.10
Antibodies and immunoglobulins. II. Normal development and changes in disease. JAMA (1965) 2.10
The immunoglobulins of mice. VI. Response to immunization. J Immunol (1965) 2.08
Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03
Solid cancers after bone marrow transplantation. J Clin Oncol (2001) 1.99
Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma. Clin Immunol Immunopathol (1983) 1.91
Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol (1998) 1.90
Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood (1999) 1.90
Early effects of HIV on CD4 lymphocytes in vivo. J Immunol (1987) 1.87
Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol (1993) 1.86
Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation (1997) 1.84
Direct detection of HIV-1 RNA from AIDS and ARC patient samples. DNA (1988) 1.79
Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood (1997) 1.75
A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J Infect Dis (1990) 1.75
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood (2000) 1.74
A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry (1990) 1.71
Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther (1997) 1.71
Cognitive processing, discovery of meaning, CD4 decline, and AIDS-related mortality among bereaved HIV-seropositive men. J Consult Clin Psychol (1998) 1.69
Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A (2001) 1.68
Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin Diagn Lab Immunol (1998) 1.65
Validation of self-reported complications by bone marrow transplantation survivors. Bone Marrow Transplant (2000) 1.64
Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant (2006) 1.63
Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens. Infect Immun (1978) 1.60
Peptic ulcer disease and other complications in patients receiving dexamethasone palliation for brain metastasis. West J Med (1982) 1.59
Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. Blood (1996) 1.57
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma. Cytotherapy (2006) 1.57
Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood (1994) 1.56
Optimism is associated with mood, coping, and immune change in response to stress. J Pers Soc Psychol (1998) 1.55
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet (1993) 1.53
Correction of Duncan's syndrome by allogeneic bone marrow transplantation. Lancet (1993) 1.53
Use of insoluble antibody for quantitative determination of small amounts of immunoglobulin. J Immunol (1969) 1.51
Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet (1993) 1.51
Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease. AIDS (1991) 1.50
Human lymphocyte membrane (HL-A) alloantigens: isolation, purification and properties. J Immunol (1969) 1.50
Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia (2008) 1.49
Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes. J Immunol (1984) 1.49
Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. Leukemia (2005) 1.49
Human T lymphocyte genetic modification with naked DNA. Mol Ther (2000) 1.47
Metabolism of human immunoglobulin D (IgD). J Clin Invest (1966) 1.46
Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant (1999) 1.46
Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis (1979) 1.46
Defective monocyte function in acquired immune deficiency syndrome (AIDS): evidence from a monocyte-dependent T-cell proliferative system. J Clin Immunol (1985) 1.46
Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood (1994) 1.45
Normal immunoglobulins and antibody response in neonatally thymectomized mice. J Natl Cancer Inst (1965) 1.45
Evidence for several cell populations active in antibody dependent cellular cytotoxicity. J Immunol (1973) 1.44
A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med (1986) 1.44
Proliferation and differentiation of lymphoid cells: studies with human lymphoid cell lines and immunoglobulin synthesis. Ann N Y Acad Sci (1971) 1.43
Synthesis of immunoglobulins by human cell lines in tissue culture. J Immunol (1967) 1.42
Topical indomethacin and sunburn. Br J Dermatol (1974) 1.41
Airborne transmission of chickenpox in a hospital. N Engl J Med (1980) 1.39
Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol (1987) 1.37
CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood (2000) 1.37
Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. J Immunol (1987) 1.34
Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst (1989) 1.34
Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2008) 1.33
Laparoscopic cholecystectomy as a "true" outpatient procedure: initial experience in 130 consecutive patients. J Gastrointest Surg (2000) 1.32
The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med (1992) 1.32
Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. N Engl J Med (1993) 1.31
Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus. Proc Natl Acad Sci U S A (1984) 1.30
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission. Leukemia (1999) 1.26